# EDGAR Filing Document

**Accession Number:** 0000794172
**File Stem:** 0001193125-23-022565
**Filing Date:** 2023-2
**Character Count:** 11500
**Document Hash:** deec80d48bceb86e383d6df54f6c58f8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-022565.hdr.sgml**: 20230202

**ACCESSION NUMBER**: 0001193125-23-022565

**CONFORMED SUBMISSION TYPE**: S-8 POS

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230202

**DATE AS OF CHANGE**: 20230202

**EFFECTIVENESS DATE**: 20230202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MERIDIAN BIOSCIENCE INC
- **CENTRAL INDEX KEY:** 0000794172
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 310888197
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** S-8 POS
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 033-78868
- **FILM NUMBER:** 23580153

**BUSINESS ADDRESS:**
- **STREET 1:** 3471 RIVER HILLS DR
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45244
- **BUSINESS PHONE:** 5132713700

**MAIL ADDRESS:**
- **STREET 1:** 3471 RIVER HILLS DRIVE
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45244

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MERIDIAN DIAGNOSTICS INC
- **DATE OF NAME CHANGE:** 19920703

**As filed with the Securities and Exchange Commission on February 2, 2023** 

**Registration Statement No. 33-38488** 

**Registration Statement No. 33-63260** 

**Registration Statement No. 33-78868** 

**Registration Statement No. 33-89214** 

**Registration Statement No. 33-65443** 

**Registration Statement No. 333-18979** 

**Registration Statement No. 333-74825** 

**Registration Statement No. 333-75312** 

**Registration Statement No. 333-122554** 

**Registration Statement No. 333-155703** 

**Registration Statement No. 333-179440** 

**Registration Statement No. 333-252538** 

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

------

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-179440** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-252538** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-155703** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-122554** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-75312** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-74825** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-18979** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-65443** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-89214** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-78868** 

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-63260** 

**POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-8 REGISTRATION STATEMENT NO. 33-38488** 

***UNDER***

***THE SECURITIES ACT OF 1933***

------

## MERIDIAN BIOSCIENCE, INC.
**(Exact name of registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| **Ohio** | **31-0888197** |
| **(State or other jurisdiction of <br>incorporation or organization)** | **(I.R.S. Employer<br>Identification Number)** |

---

**3471 River Hills Drive** 

**Cincinnati, Ohio 45244** 

**(513) 271-3700** 

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

------

**MERIDIAN BIOSCIENCE, INC. 2021 OMNIBUS AWARD PLAN** 

**MERIDIAN BIOSCIENCE, INC. 2012 STOCK INCENTIVE PLAN** 

**2004 EQUITY COMPENSATION PLAN** 

**AS AMENDED AND RESTATED THROUGH JANUARY 22, 2008** 

**2004 EQUITY COMPENSATION PLAN** 

**AMENDED AND RESTATED 1996 STOCK OPTION PLAN** 

**1999 DIRECTORS' STOCK OPTION PLAN** 

**1996 STOCK OPTION AMENDED AS EFFECTIVE JANUARY 2, 1999** 

**1996 STOCK OPTION PLAN** 

**1994 DIRECTORS' STOCK OPTION PLAN** 

**MERIDIAN DIAGNOSTICS INC. SAVINGS AND INVESTMENT PLAN** 

**1990 DIRECTORS' STOCK OPTION PLAN** 

**1986 STOCK OPTION PLAN** 

**(Full titles of plans)** 

------

**F. Mark Reuter, Esq.** 

**Keating Muething & Klekamp PLL** 

**One East Fourth Street, Suite 1400** 

**Cincinnati, Ohio 45202** 

**Telephone: (513) 579-6469** 

**Facsimile: (513) 579-6457** 

**(Name, address, including zip code, and telephone number, including area code, of agent for service)** 

---

| | |
|:---|:---|
| ***with copies to:***<br>**Jack Kenny<br>Chief Executive Officer<br>Meridian Bioscience, Inc.<br>3471 River Hills Drive<br>Cincinnati, Ohio 45244<br>(513) 271-3700<br>Facsimile (513) 271-3762** | ***with copies to:***<br>**Alex Herman<br>Robert Leung<br>Paul Hastings LLP<br>200 Park Avenue<br>New York, NY 10166<br>(212)318-6000** |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

------

**EXPLANATORY NOTE** 

**DEREGISTRATION OF SECURITIES** 

These Post-Effective Amendments (the "Post-Effective Amendments") relate relates to the following Registration Statements on Form S-8 (collectively, the "Registration Statements"), filed with the U.S. Securities and Exchange Commission (the "SEC") by Meridian Bioscience, Inc., an Ohio Corporation. (the "Company"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 333-252538, filed with the SEC on
January 29, 2021, registering 1,000,000 shares of the Company's common stock, no par value per share (the "Common Stock"), under the Meridian Bioscience, Inc. 2021 Omnibus Award Plan; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 333-179440, filed with the SEC on
February 19, 2012, registering 3,000,000 shares of the Company's Common Stock under the Meridian Bioscience, Inc. 2012 Stock Incentive Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 333-155703, filed with the SEC on
November 26, 2008, registering 1,537,500 shares of the Company's Common Stock under the 2004 Equity Compensation Plan as Amended and Restated Through January 22, 2008;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 333-122554, filed with the SEC on
February 4, 2005, registering 650,000 shares of the Company's Common Stock under the 2004 Equity Compensation Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 333-75312, filed with the SEC on
December 17, 2021, registering 500,000 shares of the Company's Common Stock under the 1999 Amended and Restated 1996 Stock Option Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 333-74825, filed with the SEC on
March 22, 1999, registering 50,000 shares of the Company's Common Stock under the 1999 Directors' Stock Option Plan and 500,000 shares of the Company's Common Stock under the 1996 Stock Option Plan Amended and Restated Effective
January 2, 1999;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 333-18979, filed with the SEC on
December 30, 1996, registering 200,000 shares of the Company's Common Stock under the 1996 Stock Option Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 33-65443, filed with the SEC on
December 28, 1995, registering 150,000 shares of the Company's Common Stock under the Meridian Diagnostics Inc. Savings and Investment Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 33-89214, filed with the SEC on
April 5, 1995, registering 225,000 shares of the Company's Common Stock under the 1986 Stock Option Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 33-78868, filed with the SEC on
May 12, 1994, registering 25,000 shares of the Company's Common Stock under the 1994 Directors' Stock Option Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 33-63260, filed with the SEC on
May 25, 1993, registering 200,000 shares of the Company's Common Stock under the 1986 Stock Option Plan; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Registration Statement No. 33-38488, filed with the SEC on
December 28, 1990, registering 282,977 shares of the Company's Common Stock under the 1986 Stock Option Plan and 15,000 shares of the Company's Common Stock under the 1990 Directors' Stock Option Plan, as amended by
post-effective amendment No.1 filed with SEC on January 7, 1991, and as further amended by post-effective amendment No. 2 filed with the SEC on May 12, 1994, deregistering 1,000 shares of the Company's Common Stock under the 1990
Directors' Stock Option Plan previously registered on the Registration Statement .

------

On January 31, 2023, pursuant to an Agreement and Plan of Merger, dated as of July 7, 2022, among the Company, SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea ("SDB"), Columbus Holding Company, a Delaware corporation ("Parent"), and Madeira Acquisition Corp., an Ohio corporation and a direct wholly owned subsidiary of Parent ("Merger Sub", and together with SDB and Parent, the "Parent Parties," and each individually a "Parent Party"). The Merger Agreement provides, among other things, that, upon the terms and subject to the conditions set forth in the Merger Agreement and in accordance with the applicable provisions of the Ohio General Corporation Law, Merger Sub will merge with and into the Company (the "Merger"), with the Company surviving the Merger as a direct wholly owned subsidiary of Parent.

In connection with the Merger, the Company has terminated all offerings of the Company's securities pursuant to existing registration statements, including the Registration Statements. Accordingly, pursuant to the undertakings contained in the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities registered that remain unsold at the termination of the offering, the Company is filing these Post-Effective Amendments to the Registration Statements to deregister, and does hereby remove from registration, all securities that had been registered under the Registration Statements that remain unsold as of the date hereof, if any.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing these Post-Effective Amendments to Form S-8 and has duly caused these Post-Effective Amendments to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cincinnati, State of Ohio, on February 2, 2023.

---

| | |
|:---|:---|
| **Meridian Bioscience, Inc.** | **Meridian Bioscience, Inc.** |
| By: | /s/ Jack Kenny |
|  | Jack Kenny<br> Chief Executive Officer |

---

No other person is required to sign these Post-Effective Amendments in reliance on Rule 478 of the Securities Act of 1933, as amended.